AAPL297.11+2.81 (+0.95%) ▲|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT374.78+0.84 (+0.22%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|AAPL297.11+2.81 (+0.95%) ▲|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT374.78+0.84 (+0.22%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|
24.7 C
New York
Wednesday, June 24, 2026

Tag: evaluation

newssourceFORcompanyinformationcontent1marketreleases

SUMEC PHONO Leads with Cutting-Edge PV Innovations at 2025 SNEC

SHANGHAI, June 17, 2025 /PRNewswire/ -- From June 11–13, 2025, the SNEC PV+ 2025 International Photovoltaic Power Generation and Smart Energy Conference & Exhibition—a flagship...

Carbon Streaming Announces Corporate Update and Legend Removal Process for All U.S. Investors From the 2021 Financings

Carbon Streaming Announces Corporate Update And Legend Removal Process For All U.S. Investors From The 2021 Financings

Duke Energy Indiana agrees to Cayuga coal unit feasibility study in addition to building new gas units on-site

The study will explore the possibility of a sale of existing coal units Settlement with state's coal producers is aligned with Indiana Governor Mike...

Genomics announces next stage of global roll-out of its predictive clinical tool Health Insights – the first ever UKCA-marked and MHRA registered test that...

Health Insights UK is Genomics' predictive clinical tool. It provides genetic risk testing as a secure, end-to-end solution based on a saliva sample that...

ReconAfrica Announces Closing of C$19 Million Underwritten Offering, Including the Full Exercise of the Over-Allotment Option

Kavango West 1X (Prospect I) rig mobilization to occur in June 2025 
Kavango West 1X (Prospect I) rig mobilization to occur in June 2025

COPPER GIANT PROVIDES AN EXPLORATION UPDATE ON ITS 14,000-METRES DRILLING PROGRAM AT THE MOCOA PORPHYRY COPPER-MOLYBDENUM PROJECT, PUTUMAYO, COLOMBIA

Two rigs turning from new pads after heavy rainfall; program back on schedule.MD-047 at 800 m of planned 900 m; first core samples have been...

Ascend Commences Orderly Wind Down of HMD Production Facility in Lianyungang

All other facilities continue to operate as usual; shipments and product delivery to continue in normal course Remains on track to emerge from Chapter...

Industry-First! SpiroxLTS Reveals the True Quality of TGV Laser-Modified Vias Accelerating TGV Mass Production

HSINCHU, June 17, 2025 /PRNewswire/ -- Professional semiconductor equipment provider Spirox Corporation (TWSE: 3055) has introduced the industry-first SpiroxLTS (Spirox Laser Tomography Scanning) technology. Leveraging...

Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates

-- Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- SHANGHAI, June...

Shasqi Publishes Landmark Study in Clinical Cancer Research: First-in-Human Use of Click Chemistry Unlocks New Opportunities for Targeted Cancer Therapies

Shasqi is a leader in the translational application of click chemistry, a Nobel Prize winning technology, and the first company to use this technology in...

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate...

MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to initiate a Phase 2/3 pivotal confirmatory trial of OCU410ST, a modifier gene therapy candidate being developed for all Stargardt disease (ABCA4-associated retinopathies). The FDA previously granted Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation for OCU410ST for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa 19, and cone-rod dystrophy 3.

VEON Announces USD 35 Million Share Buyback

Announcement marks the third phase of USD 100 million share buyback program 

RayStation used for pioneering clinical milestone at Helsinki University Hospital – first treatment with accelerator-based BNCT in Europe

STOCKHOLM, June 16, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in...

Abbisko Therapeutics Completes First Patient Dosing in Registrational Study of Irpagratinib for HCC

SHANGHAI, June 15, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) today announced that it has completed first patient dosing in a registrational study of...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEvaluation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers